Neurodegeneration is accelerated in the brain of patients with PD owing to increased amounts of inflammation-promoting signaling molecules, such as IFN-γ, IL-1β, 6, and TNF (Isik et al., 2023). This evidence concerns the gene IL1B and Parkinson disease.